Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00930_DB01132_nanopub.RAIqKfrkBj9w1R7ijujcHg0GVULeI8Ts89V-dL5uHPfSc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00930_DB01132 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00930_DB01132 label "DDI between Colesevelam and Pioglitazone - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents. [drugbank_resource:DB00930_DB01132]" assertion.
- drugbank_resource:DB00930_DB01132 identifier "drugbank_resource:DB00930_DB01132" assertion.
- drugbank_resource:DB00930_DB01132 title "DDI between Colesevelam and Pioglitazone - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents." assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01132 assertion.
- drugbank:DB01132 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01132 assertion.